Clinical Trials Logo

Macroglossia clinical trials

View clinical trials related to Macroglossia.

Filter by:
  • None
  • Page 1

NCT ID: NCT03499808 Active, not recruiting - Constipation Clinical Trials

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Start date: June 6, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.

NCT ID: NCT01458613 Withdrawn - Lung Diseases Clinical Trials

Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

BioMaroteaux
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Maroteaux-Lamy disease from blood

NCT ID: NCT01457443 Withdrawn - Lung Disease Clinical Trials

Biomarker for Pompe Disease (BioPompe)

BioPompe
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Pompe disease from blood (plasma)